Glucose intolerance as an additional test of the protein effect on serum cholesterol: clinical cases

Effects of kappa- and mu-opioid receptor agonists on Ca2+ channels in neuroblastoma cells: involvement of the orphan opioid receptor.

European journal of pharmacology·1999

Mutational analysis of the putative fusion domain of Ebola virus glycoprotein.

Journal of virology·1999

Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents.

Antimicrobial agents and chemotherapy·1999

Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.

International journal of pharmaceutics·1999

[Congenital defects of antithrombin III and proteins C and S during pregnancy].

Revista medica de Chile·1999

[Clinical characterization, molecular and FISH studies in 80 patients with clinical suspicion of Williams-Beuren syndrome].

Medicina clinica·1999

Lysosomal dysfunction in vascular smooth muscle cells: Mechanisms and therapeutic targets in vascular disease.

Atherosclerosis·2026

IL-21R blockade reduces inflammation and atherosclerosis in LDL receptor deficient mice.

Atherosclerosis·2026

Prediabetes: Impact on cardiovascular risk and emerging therapeutic strategies.

Atherosclerosis·2026

The benefit of LDL-C levels below 55 mg/dL in ESKD patients under statin treatment: A target trial emulation study.

Atherosclerosis·2026

Roles of primary cilia in cardiovascular diseases: mechanisms and therapeutic prospects.

Atherosclerosis·2026

Discordant fatty acid profile drives residual inflammatory risk in metabolically vulnerable patients with low atherogenic lipoprotein burden.

Atherosclerosis·2026

Gut microbiota: a novel key player in urinary stone formation - from oxalate metabolism to systemic regulation.

Gut microbes·2026

Added Value of Quadriceps Muscle Layer Thickness to modified Nutrition Risk in the Critically Ill (mNUTRIC) Score in Predicting Clinical Outcomes in Critically Ill Patients: A Prospective Observational Study.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine·2026

Diabetes-associated Alterations in the Gut Microbiota-metabolite Profile of NAFLD Under Complex Clinical Conditions.

Journal of clinical and experimental hepatology·2026

Gut microbiota-host adaptive immune interactions in type 2 diabetes mellitus: mechanisms, disease progression, and microbiota-based therapeutic strategies.

Frontiers in microbiology·2026

Integrative multi-omics analysis prioritizes compartment-specific candidate targets of gut microbiota metabolites in diabetic kidney disease.

Frontiers in immunology·2026

Nutriments: Integrating Patient-Centered Nutrition Education for Medical Students within a Clinical Presentation Framework.

Medical science educator·2026

Related Experiment Videos

Glucose intolerance as an additional test of the protein effect on serum cholesterol: clinical cases

Related Concept Videos

Effects of kappa- and mu-opioid receptor agonists on Ca2+ channels in neuroblastoma cells: involvement of the orphan opioid receptor.

Mutational analysis of the putative fusion domain of Ebola virus glycoprotein.

Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents.

Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.

[Congenital defects of antithrombin III and proteins C and S during pregnancy].

[Clinical characterization, molecular and FISH studies in 80 patients with clinical suspicion of Williams-Beuren syndrome].

Lysosomal dysfunction in vascular smooth muscle cells: Mechanisms and therapeutic targets in vascular disease.

IL-21R blockade reduces inflammation and atherosclerosis in LDL receptor deficient mice.

Prediabetes: Impact on cardiovascular risk and emerging therapeutic strategies.

The benefit of LDL-C levels below 55 mg/dL in ESKD patients under statin treatment: A target trial emulation study.

Roles of primary cilia in cardiovascular diseases: mechanisms and therapeutic prospects.

Discordant fatty acid profile drives residual inflammatory risk in metabolically vulnerable patients with low atherogenic lipoprotein burden.

Gut microbiota: a novel key player in urinary stone formation - from oxalate metabolism to systemic regulation.

Added Value of Quadriceps Muscle Layer Thickness to modified Nutrition Risk in the Critically Ill (mNUTRIC) Score in Predicting Clinical Outcomes in Critically Ill Patients: A Prospective Observational Study.

Diabetes-associated Alterations in the Gut Microbiota-metabolite Profile of NAFLD Under Complex Clinical Conditions.

Gut microbiota-host adaptive immune interactions in type 2 diabetes mellitus: mechanisms, disease progression, and microbiota-based therapeutic strategies.

Integrative multi-omics analysis prioritizes compartment-specific candidate targets of gut microbiota metabolites in diabetic kidney disease.

Nutriments: Integrating Patient-Centered Nutrition Education for Medical Students within a Clinical Presentation Framework.

Related Experiment Videos

Glucose intolerance as an additional test of the protein effect on serum cholesterol: clinical cases

Related Concept Videos

Related Articles